Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Glioma is the most common and aggressive type of primary brain malignant tumor with limited treatment approaches. Methyltransferase-like 7B (METTL7B) is associated with the pathogenesis of several diseases but is rarely studied in glioma. In this study, 1,493 glioma samples (data from our cohort, TCGA, and CGGA) expressing METTL7B were used to explore its prognostic value and mechanism in the immune microenvironment. Results showed that high expression of METTL7B is associated with poor prognosis and abundant immunosuppressive cells. Further, functional enrichment showed that METTL7B is involved in the negative regulation of immunity and carcinogenic signaling pathways. Moreover, a METTL7B-related prognostic signature constructed based on multi-omics showed a good prediction of the overall survival (OS) time of glioma patients. In conclusion, METTL7B is a potential prognostic biomarker. In addition, the prognostic prediction model constructed in this study can be used in clinical setups for the development of novel effective therapeutic strategies for glioma patients and improving overall survival.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484875 | PMC |
| http://dx.doi.org/10.3389/fmolb.2021.727481 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HOXB4/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification.
Biol Direct
March 2025
Department of Emergency, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, 450002, China.
Background: Hepatocellular carcinoma is a fatal malignancy that lacking specific therapies. Homeobox B4 (HOXB4) was negatively correlated with poor prognosis in cancers, but its role in hepatocellular carcinoma has not been elucidated.
Results: We confirmed that HOXB4 was downregulated in hepatocellular carcinoma tissues and lower HOXB4 expression associated with poor prognosis.
Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers.
Mol Biol Rep
January 2025
Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Background: The methyltransferase gene family is known for its diverse biological functions and critical role in tumorigenesis. This study aimed to identify these family genes in common gastrointestinal (GI) cancers using comprehensive methodologies.
Methods: Gene identification involved analysis of scientific literature and insights from The Cancer Genome Atlas (TCGA) database.
Investigation of risk signatures associated with anoikis in thyroid cancer through integrated transcriptome and Mendelian randomization analysis.
Front Endocrinol (Lausanne)
November 2024
Department of Nuclear Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Article Synopsis
- * Researchers used various methods to analyze gene expression and develop a risk signature based on six identified genes that could predict survival and assess treatment effectiveness in THCA patients.
- * The findings indicate a significant causal link between the gene CXCL8 and THCA risk, suggesting higher expression levels could lead to worse outcomes, which was confirmed through additional experimental methods.
Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9.
Discov Oncol
November 2024
Affiliated Stomatology Hospital of Guilin Medical University, Guilin, 541004, Guangxi, People's Republic of China.
Background: S100A8/A9, an innate immune protein, significantly regulates inflammatory processes and immune responses. While S100A8/A9 has been linked to various diseases, its association with head and neck squamous cell carcinoma (HNSCC) remains unclear.
Methods: Samples from the Cancer Genome Atlas (TCGA) were categorized into groups with low and high expression of S100A8/A9.
New genetic biomarkers from transcriptome RNA-sequencing for Mycobacterium tuberculosis complex and Mycobacterium avium complex infections by bioinformatics analysis.
Sci Rep
July 2024
Department of Tuberculosis Control and Prevention, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Mingshi 568#, Shangcheng, Hangzhou, 310021, Zhejiang, China.
Article Synopsis
- The study focuses on identifying differentially expressed genes (DEGs) and biological pathways in mycobacterial infections using bioinformatics to improve understanding of these diseases.
- Researchers utilized Gene Ontology (GO) and KEGG pathway enrichment analysis, along with LASSO regression, to analyze 1,057 DEGs from two datasets related to NTM, latent TB infection (LTBI), and active TB disease (ATB).
- Key findings showed that specific genes, like METTL7B and HBA1/2, serve as informative markers for differentiating between LTBI and ATB, which could enhance diagnosis and understanding of Mycobacterium infections.